首页 | 本学科首页   官方微博 | 高级检索  
     

STAT1表达对高级别浆液性卵巢癌患者生存的影响分析
引用本文:李 玮1,张 静2,朱根海1,吴秀荣1. STAT1表达对高级别浆液性卵巢癌患者生存的影响分析[J]. 现代肿瘤医学, 2020, 0(9): 1539-1542. DOI: 10.3969/j.issn.1672-4992.2020.09.026
作者姓名:李 玮1  张 静2  朱根海1  吴秀荣1
作者单位:1.海南省人民医院妇科,海南 海口 570000;2.陕西中医药大学第二附属医院妇科,陕西 咸阳 712000
摘    要:目的:探讨STAT1在高级别浆液性卵巢癌(HGSC)组织中的表达特点及其与预后的关系。方法:选取我院2005年1月至2015年1月106例HGSC患者病理活检组织标本构建组织微阵列,采用免疫组织化学染色法检测所有活检组织标本中STAT1的表达情况,分析STAT1表达对HGSC患者总体生存期(OS)的影响。结果:在HGSC中STAT1的高表达与高OS显著相关(P=0.013)。Cox比例风险回归模型显示,STAT1表达、FIGO分期和细胞减灭术状态对HGSC患者OS均有独立影响。结论:STAT1高表达与HGSC患者更高的OS存在显著相关性,可以作为预后判断的生物学标志物。

关 键 词:高级别浆液性卵巢癌  STAT1  预后因子  总体生存率  免疫组织化学

Clinical significance of STAT1 expression in high grade serous ovarian cancer
Li Wei1,Zhang Jing2,Zhu Genhai1,Wu Xiurong1. Clinical significance of STAT1 expression in high grade serous ovarian cancer[J]. Journal of Modern Oncology, 2020, 0(9): 1539-1542. DOI: 10.3969/j.issn.1672-4992.2020.09.026
Authors:Li Wei1  Zhang Jing2  Zhu Genhai1  Wu Xiurong1
Affiliation:1.Department of Gynecology,Hainan Provincial People's Hospital,Hainan Haikou 570000,China;2.Department of Gynecology,the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine,Shaanxi Xianyang 712000,China.
Abstract:Objective:To investigate the relationship of STAT1 expression characteristics with clinical prognosis in the high grade serous ovarian cancer (HGSC).Methods:Expression of STAT1 was determined with immunohistochemical staining of a tissue microarray in 106 specimens of HGSC.The relationship of STAT1 expression levels with prognosis of HGSC patients was analyzed.Results:Kaplan-Meier survival analysis demonstrated that patients with high STAT1 expression was significantly associated with improved overall survival(P=0.013).Proportional hazards regression Cox models showed STAT1 expression,FIGO stage and cytoreduction had independent effect on overall survival.Conclusion:High STAT1 expression is associated with improved overall survival in HGSC and may serve as a prognostic marker.
Keywords:HGSC   STAT1   prognostic factor   overall survival   immunohistochemistry
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号